Net Income

The global professional services giant is simplifying its identity, changing its ticker to MRSH, and preparing to reveal its Q4 results in a pivotal January.

A successful demonstration of Revoltz's compact electric cargo vehicle to Israeli officials could signal a major shift in last-mile logistics.

E-commerce firm iPower has invested its cash reserves into Bitcoin and Ethereum, a bold move that analysts see as both a risky gamble and a strategic pivot.

Mixed Martial Arts Group lands $3 million in funding, with Donald Trump Jr. investing, to fuel its ambitious blockchain-based fan engagement platform.

WORK Medical's RMB 10M deal for its AI blood analyzer in East China signals a major push. Its unique 'interpretable AI' may be the key to success.

Casey Plummer's appointment signals NDBT's strategic focus on Dallas's property market and a deeper commitment to community-led development initiatives.

Verizon's Q4 report will reveal if its FWA growth can offset mobile pressures and prove the new CEO's strategy is paying off for investors and customers.

Mount Logan Capital offers shareholders a 14% premium in a $15M tender offer, signaling confidence despite mixed financials and a complex market identity.

A CETY affiliate moves its 2.2 MW Vermont plant through regulatory hurdles, but past setbacks, new technology, and financial questions loom large.

Capital Clean Energy Carriers Corp. orders three advanced LNG carriers, positioning itself to capitalize on a projected surge in global gas demand.

A landmark journal issue introduces a new framework for facial rejuvenation, moving beyond outdated norms to embrace individualized, culturally sensitive care.

Eightco Holdings bets big on its own stock with a $125M buyback, banking on its Worldcoin treasury and a vision for AI-proof digital identity.

INOVIO's promising non-surgical treatment for a rare disease faces FDA scrutiny, casting doubt on its fast-track approval and impacting patient hopes.

With $13.2 billion in assets and 3.41% of all ETH, Bitmine is on a quest for market dominance. A crucial shareholder vote will decide its future.

A Korean pet food brand's surprise win over tech giants at a top pitch event signals a major shift in what venture capitalists value. Here's why.

Setrusumab, a promising drug for Osteogenesis Imperfecta, failed to reduce fractures in key trials, triggering a market collapse and strategic overhaul.

With its 'Results Your Way' plan, the fitness giant is rolling out personalized coaching, recovery zones, and Pilates to compete in a changing market.

TRON founder Justin Sun injects $18M into Nasdaq-listed Tron Inc., bolstering its crypto treasury and cementing its unique dual business model.

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

As 374Water pushes its waste-destroying tech to market, a new board member with deep financial expertise and a history as a long-term investor joins.